Oral Thin Films

Global Market Trajectory & Analytics

MCP16658

EXECUTIVE ENGAGEMENTS

OUTREACH

477
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

93
Interactions with Platform & by Email

PARTICIPANTS

19
Unique # Participated

VALIDATIONS

9
Responses Validated*

COMPETITORS

48
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

106

PAGES

184

EDITION

8

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Oral Thin Films estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at aCAGR of 12.3% over the period 2020-2027. Sublingual Film, one of the segments analyzed in the report, is projected to record 11.6% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fast Dissolving Dental/Buccal Film segment is readjusted to a revised 12.8% CAGR for the next 7-year period.
The Oral Thin Films market in the U.S. is estimated at US$772.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 11.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 10.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR.

SELECT PLAYERS

Allergan plc; Aquestive Therapeutics Inc.; Indivior plc; IntelGenx Corp.; LTS Lohmann Therapie-Systeme AG; Mylan NV; NAL Pharma; Novartis AG; Pfizer, Inc.; Solvay; Sumitomo Dainippon Pharma Co., Ltd.; ZIM Laboratories Limited

SEGMENTS

» Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indications) » Distribution Channel (Hospital Pharmacies, Drug Store, Retail Pharmacies, E-Commerce) » Product Type (Sublingual Film, Fast Dissolving Dental/Buccal Film)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Oral Thin Films by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Sublingual Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Sublingual Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Fast Dissolving Dental/Buccal Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Fast Dissolving Dental/Buccal Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Opioid Dependence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Opioid Dependence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Nausea & Vomiting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Nausea & Vomiting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Drug Store by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for E-Commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for E-Commerce by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
USA Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
USA Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Canada Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Canada Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Japan Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Japan Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
China Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
China Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Oral Thin Films by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Europe Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Europe Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
France Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
France Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Germany Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Germany Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Italy Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Italy Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
UK Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
UK Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2020 & 2027
Rest of World Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2020 & 2027
Rest of World Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2020 & 2027
Total Companies Profiled: 48

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com